Insulet Corporation is a notable mention in various financial activities. The company is a hot pick for several investors like Swedbank AB, Osaic Holdings Inc, Beacon Investment Advisory Services, and Munro Partners who have increased their stakes in the company. On the other hand, Squarepoint Ops LLC, Perpetual Ltd and the Central Pacific Bank Trust Division have decreased their holdings. The company's Q2 revenue surged by 32.9% to $649M leading them to raise their full-year guidance. Despite fluctuations in stock performance, Truist maintains the company as its top MedTech pick for 2026 and Evercore ISI Group initiated coverage with an outperform recommendation. However, the company’s business is yet to catch up with its share price. With regards to product development, Insulet’s Omnipod has received FDA approval for its enhancements and the expansion of their U.S. recycling program diverts millions of pods from landfills, pushing forward a sustainable future. Insulet is also participating in the 44th Annual J.P. Morgan Healthcare Conference.
Insulet Corporation PODD News Analytics from Fri, 09 May 2025 07:00:00 GMT to Sat, 27 Dec 2025 10:47:23 GMT -
Rating 7
- Innovation 5
- Information 6
- Rumor -2
